dipyridamole has been researched along with Liver Failure in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Liver Failure: Severe inability of the LIVER to perform its normal metabolic functions, as evidenced by severe JAUNDICE and abnormal serum levels of AMMONIA; BILIRUBIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASES; and albumin/globulin ratio. (Blakiston's Gould Medical Dictionary, 4th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abele, JT | 1 |
| Raubenheimer, M | 1 |
| Bain, VG | 1 |
| Wandzilak, G | 1 |
| AlHulaimi, N | 1 |
| Coulden, R | 1 |
| deKemp, RA | 1 |
| Klein, R | 1 |
| Williams, RG | 1 |
| Warshawski, RS | 1 |
| Lalonde, LD | 1 |
1 other study available for dipyridamole and Liver Failure
| Article | Year |
|---|---|
Quantitative blood flow evaluation of vasodilation-stress compared with dobutamine-stress in patients with end-stage liver disease using
Topics: Adult; Aged; Coronary Circulation; Dipyridamole; Dobutamine; End Stage Liver Disease; Female; Humans | 2020 |